Salmond (second left) surrounded by BASF scientists and management. Kelliher (far right) told us: “As soon as I met BASF I knew they were the perfect home for Equateq because Equateq was a small entrepreneurial company with a break-through technology but we were very weak in other areas like support infrastructure and systems whereas they are quite the opposite.”
“We have a lot of new kit in and built up our quality systems. We were under resourced, now we are properly resourced.”
The latest changes at Bayer, biopharma, and the winner of Professional Woman of the Year in this...
This week's pharmaceutical changes begin with the election of Reuters' head to the Board of Pfizer.
Big changes in biologics in this week's column, as we round up the pharma industry's new scientific...